Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.

Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, Yoshida Y, Takayama T, Imai H, Nozawa K, Sangai T, Yoshimura A, Hasegawa Y, Yamaguchi T, Shimozuma K, Ohashi Y.

PLoS One. 2019 Jan 9;14(1):e0208118. doi: 10.1371/journal.pone.0208118. eCollection 2019.

2.

Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer.

Ishigami E, Sakakibara M, Sakakibara J, Masuda T, Fujimoto H, Hayama S, Nagashima T, Sangai T, Nakagawa A, Nakatani Y, Otsuka M.

Breast Cancer. 2019 Mar;26(2):180-189. doi: 10.1007/s12282-018-0910-4. Epub 2018 Sep 22.

PMID:
30244409
3.

Hormonal Therapy Resistant Estrogen-receptor Positive Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment Selection in Japan.

Iwamoto T, Taira N, Fujisawa T, Araki K, Sakamaki K, Sangai T, Kikawa Y, Shien T, Takao S, Sato M, Goto Y, Yoshida T, Takahashi M, Aihara T, Mukai H.

Acta Med Okayama. 2018 Aug;72(4):369-374. doi: 10.18926/AMO/56172.

4.

Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin-bound paclitaxel for human epidermal growth factor receptor 2-negative breast cancer.

Ishigami E, Sakakibara M, Sakakibara J, Iwase T, Hayama S, Masuda T, Nakagawa A, Nagashima T, Sangai T, Fujimoto H, Otsuka M.

Mol Clin Oncol. 2017 Dec;7(6):1079-1082. doi: 10.3892/mco.2017.1464. Epub 2017 Oct 20.

5.

Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.

Woo SU, Sangai T, Akcakanat A, Chen H, Wei C, Meric-Bernstam F.

Oncogenesis. 2017 Oct 9;6(10):e385. doi: 10.1038/oncsis.2017.86.

6.

An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer.

Iwase T, Sangai T, Sakakibara M, Sakakibara J, Ishigami E, Hayama S, Nakagawa A, Masuda T, Tabe S, Nagashima T.

Mol Clin Oncol. 2017 Feb;6(2):266-270. doi: 10.3892/mco.2016.1101. Epub 2016 Dec 5.

7.

Rapid and cost-effective high-throughput sequencing for identification of germline mutations of BRCA1 and BRCA2.

Ahmadloo S, Nakaoka H, Hayano T, Hosomichi K, You H, Utsuno E, Sangai T, Nishimura M, Matsushita K, Hata A, Nomura F, Inoue I.

J Hum Genet. 2017 Apr;62(5):561-567. doi: 10.1038/jhg.2017.5. Epub 2017 Feb 9.

PMID:
28179634
8.

[Breast-Conserving Surgery Using Real-Time Virtual Sonography in a Breast Cancer Patient Who Received Neoadjuvant Chemotherapy - ACase Report].

Sakakibara J, Sakakibara M, Sangai T, Iwase T, Nagashima T.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1461-1463. Japanese.

PMID:
28133023
9.

Expression of cell polarity protein scribble differently affects prognosis in primary tumor and lymph node metastasis of breast cancer patients.

Sakakibara J, Sakakibara M, Shiina N, Fujimori T, Okubo Y, Fujisaki K, Nagashima T, Sangai T, Nakatani Y, Miyazaki M.

Breast Cancer. 2017 May;24(3):393-399. doi: 10.1007/s12282-016-0715-2. Epub 2016 Aug 25.

PMID:
27562784
10.

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, Eterovic AK, Sangai T, Holder AM, Sharma C, Chen H, Do KA, Tarco E, Gagea M, Naff KA, Sahin A, Multani AS, Black DM, Mittendorf EA, Bedrosian I, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F.

PLoS One. 2016 Mar 8;11(3):e0151121. doi: 10.1371/journal.pone.0151121. eCollection 2016. No abstract available.

11.

Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery.

Shiina N, Sakakibara M, Fujisaki K, Iwase T, Nagashima T, Sangai T, Kubota Y, Akita S, Takishima H, Miyazaki M.

Eur J Surg Oncol. 2016 Apr;42(4):481-8. doi: 10.1016/j.ejso.2016.01.004. Epub 2016 Jan 22.

PMID:
26852107
12.

[The Case of a Patient with Invasive Lobular Carcinoma with Solitary Metastasis in Pectoralis Major Muscle].

Iwase T, Sangai T, Sakakibara M, Nagashima T, Masuda T, Ishigami E, Hayama S, Sakakibara J, Miyazaki M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1815-7. Japanese.

PMID:
26805182
13.

[Long-Term Outcome of Radiofrequency Ablation Therapy for Breast Cancer].

Nagashima T, Sakakibara M, Sangai T, Sakakibara J, Iwase T, Hayama S, Ishigami E, Masuda T, Nakagawa A, Miyazaki M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1788-90. Japanese.

PMID:
26805173
14.

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients.

Iwase T, Sangai T, Nagashima T, Sakakibara M, Sakakibara J, Hayama S, Ishigami E, Masuda T, Miyazaki M.

Cancer Med. 2016 Jan;5(1):41-8. doi: 10.1002/cam4.571. Epub 2015 Dec 2.

15.

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, Eterovic AK, Sangai T, Holder AM, Sharma C, Chen H, Do KA, Tarco E, Gagea M, Naff KA, Sahin A, Multani AS, Black DM, Mittendorf EA, Bedrosian I, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F.

PLoS One. 2015 Sep 1;10(9):e0136851. doi: 10.1371/journal.pone.0136851. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0151121.

16.

Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1.

Fujisaki K, Fujimoto H, Sangai T, Nagashima T, Sakakibara M, Shiina N, Kuroda M, Aoyagi Y, Miyazaki M.

Breast Cancer Res Treat. 2015 Apr;150(2):255-63. doi: 10.1007/s10549-015-3318-2. Epub 2015 Feb 27.

PMID:
25721605
17.

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.

Hassan B, Akcakanat A, Sangai T, Evans KW, Adkins F, Eterovic AK, Zhao H, Chen K, Chen H, Do KA, Xie SM, Holder AM, Naing A, Mills GB, Meric-Bernstam F.

Oncotarget. 2014 Sep 30;5(18):8544-57.

18.

Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.

Blanco E, Sangai T, Wu S, Hsiao A, Ruiz-Esparza GU, Gonzalez-Delgado CA, Cara FE, Granados-Principal S, Evans KW, Akcakanat A, Wang Y, Do KA, Meric-Bernstam F, Ferrari M.

Mol Ther. 2014 Jul;22(7):1310-1319. doi: 10.1038/mt.2014.27. Epub 2014 Feb 26.

19.

Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.

Sangai T, Akcakanat A, Chen H, Tarco E, Wu Y, Do KA, Miller TW, Arteaga CL, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F.

Clin Cancer Res. 2012 Oct 15;18(20):5816-28. doi: 10.1158/1078-0432.CCR-12-1141. Epub 2012 Aug 29.

20.

Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment.

Blanco E, Sangai T, Hsiao A, Ferrati S, Bai L, Liu X, Meric-Bernstam F, Ferrari M.

Cancer Lett. 2013 Jul 1;334(2):245-52. doi: 10.1016/j.canlet.2012.07.027. Epub 2012 Jul 31.

PMID:
22858582
21.

PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.

Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rashid A, Crosby K, Dong M, Phan AT, Wolff RA, Gupta S, Mills GB, Yao J.

Clin Cancer Res. 2012 Mar 15;18(6):1777-89. doi: 10.1158/1078-0432.CCR-11-2123.

22.

Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.

Kadowaki M, Sangai T, Nagashima T, Sakakibara M, Yoshitomi H, Takano S, Sogawa K, Umemura H, Fushimi K, Nakatani Y, Nomura F, Miyazaki M.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1105-15. doi: 10.1007/s00432-010-0974-9. Epub 2011 Jan 21.

PMID:
21253761
23.

Surrounding rim formation and reduction in size after radiofrequency ablation for primary breast cancer.

Nagashima T, Sakakibara M, Sangai T, Kazama T, Fujimoto H, Miyazaki M.

Jpn J Radiol. 2009 Jun;27(5):197-204. doi: 10.1007/s11604-009-0322-7. Epub 2009 Jun 25.

PMID:
19554412
24.

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.

Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M, Ochiai A.

Int J Cancer. 2009 Sep 15;125(6):1276-84. doi: 10.1002/ijc.24378.

25.

Tumor reduction rate predicts early recurrence in patients with breast cancer failing to achieve complete response to primary chemotherapy.

Nagashima T, Sakakibara M, Sangai T, Kazama T, Nakatani Y, Miyazaki M.

Breast Cancer. 2010 Apr;17(2):125-30. doi: 10.1007/s12282-009-0117-9. Epub 2009 May 21.

PMID:
19459030
26.

Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.

Nakamura R, Sakakibara M, Nagashima T, Sangai T, Arai M, Fujimori T, Takano S, Shida T, Nakatani Y, Miyazaki M.

Eur J Cancer. 2009 Aug;45(12):2123-31. doi: 10.1016/j.ejca.2009.03.024. Epub 2009 Apr 22.

PMID:
19398324
27.

Breast cancer with cartilaginous and/or osseous metaplasia.

Yoichi T, Nagashima T, Yagata H, Yoshida K, Suzuki M, Fujimori T, Sangai T, Nakatani Y, Miyazaki M.

Breast Cancer. 2009;16(3):234-7. doi: 10.1007/s12282-008-0090-8. Epub 2009 Jan 30. Review.

PMID:
19184279
28.

Breast-conserving surgery using projection and reproduction techniques of surgical-position breast MRI in patients with ductal carcinoma in situ of the breast.

Sakakibara M, Nagashima T, Sangai T, Nakamura R, Fujimoto H, Arai M, Kazama T, Hashimoto H, Nakatani Y, Miyazaki M.

J Am Coll Surg. 2008 Jul;207(1):62-8. doi: 10.1016/j.jamcollsurg.2007.12.034. Epub 2008 Apr 14.

PMID:
18589363
29.

Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.

Sangai T, Fujimoto H, Miyamoto S, Maeda H, Nakamura M, Ishii G, Nagai K, Nagashima T, Miyazaki M, Ochiai A.

Clin Exp Metastasis. 2008;25(4):401-10. doi: 10.1007/s10585-008-9144-8. Epub 2008 Feb 29.

PMID:
18307047
30.

Breast-conserving surgery using supine magnetic resonance imaging in breast cancer patients receiving neoadjuvant chemotherapy.

Nakamura R, Nagashima T, Sakakibara M, Sangai T, Fujimoto H, Arai M, Shida T, Kaneoya K, Ueda T, Nakatani Y, Hashimoto H, Miyazaki M.

Breast. 2008 Jun;17(3):245-51. Epub 2007 Nov 19.

PMID:
18024036
31.

Ectopic breast tissue in axillary lymph node.

Kadowaki M, Nagashima T, Sakata H, Sakakibara M, Sangai T, Nakamura R, Fujimoto H, Arai M, Onai Y, Nagai Y, Miyazawa Y, Miyazaki M.

Breast Cancer. 2007;14(4):425-8.

32.

Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3.

Sano A, Sangai T, Maeda H, Nakamura M, Hasebe T, Ochiai A.

Int J Oncol. 2007 Jun;30(6):1493-8.

PMID:
17487371
33.

Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.

Miyamoto S, Nakamura M, Yano K, Ishii G, Hasebe T, Endoh Y, Sangai T, Maeda H, Shi-Chuang Z, Chiba T, Ochiai A.

Cancer Sci. 2007 May;98(5):685-91. Epub 2007 Mar 14.

34.

Hormonal stimulation increases the recruitment of bone marrow-derived myoepithelial cells and periductal fibroblasts into the mammary gland.

Sangai T, Ishii G, Fujimoto H, Ikehara A, Ito T, Hasebe T, Magae J, Nagashima T, Miyazaki M, Ochiai A.

Biochem Biophys Res Commun. 2006 Aug 11;346(4):1173-80. Epub 2006 Jun 13.

PMID:
16793011
35.

Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouse.

Araki K, Sangai T, Miyamoto S, Maeda H, Zhang SC, Nakamura M, Ishii G, Hasebe T, Kusaka H, Akiyama T, Tokuda Y, Nagai K, Minami H, Ochiai A.

Int J Cancer. 2006 May 15;118(10):2602-8.

36.

In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma.

Ishii G, Sangai T, Ito T, Hasebe T, Endoh Y, Sasaki H, Harigaya K, Ochiai A.

Int J Cancer. 2005 Nov 1;117(2):212-20.

37.

Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers.

Miyamoto S, Nakamura M, Shitara K, Nakamura K, Ohki Y, Ishii G, Goya M, Kodama K, Sangai T, Maeda H, Shi-Chuang Z, Chiba T, Ochiai A.

Clin Cancer Res. 2005 May 1;11(9):3494-502.

38.

Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma.

Kodama K, Ishii G, Miyamoto S, Goya M, Zhang SC, Sangai T, Yoshikawa T, Hasebe T, Hitomi Y, Izumi K, Ochiai A.

Int J Cancer. 2005 Oct 10;116(6):876-84.

39.

In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions.

Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, Magae J, Ochiai A.

Stem Cells. 2005 May;23(5):699-706.

40.

Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma.

Sangai T, Ishii G, Kodama K, Miyamoto S, Aoyagi Y, Ito T, Magae J, Sasaki H, Nagashima T, Miyazaki M, Ochiai A.

Int J Cancer. 2005 Jul 20;115(6):885-92.

41.

Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.

Nakamura M, Miyamoto S, Maeda H, Zhang SC, Sangai T, Ishii G, Hasebe T, Endoh Y, Saito N, Asaka M, Ochiai A.

Clin Cancer Res. 2004 Dec 15;10(24):8434-41.

42.

Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.

Goya M, Miyamoto S, Nagai K, Ohki Y, Nakamura K, Shitara K, Maeda H, Sangai T, Kodama K, Endoh Y, Ishii G, Hasebe T, Yonou H, Hatano T, Ogawa Y, Ochiai A.

Cancer Res. 2004 Sep 1;64(17):6252-8.

43.

Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction.

Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe T, Kanomata N, Endoh Y, Okumura C, Okuhara Y, Magae J, Emura M, Ochiya T, Ochiai A.

Biochem Biophys Res Commun. 2003 Sep 12;309(1):232-40.

PMID:
12943687

Supplemental Content

Loading ...
Support Center